1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A : Data from the PedNet Study Group
- Contribution to journal › Article
-
Mark
Intracranial hemorrhage before start of prophylaxis in children with hemophilia : incidence, timing, and potential for prevention
- Contribution to journal › Article
- 2024
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
- Contribution to journal › Article
-
Mark
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia : data from the PedNet cohort
- Contribution to journal › Article
- 2023
-
Mark
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts
- Contribution to journal › Article
- 2022
-
Mark
Long-term joint outcomes in adolescents with moderate or severe haemophilia A
- Contribution to journal › Article
- 2021
-
Mark
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
- Contribution to journal › Article
- 2020
-
Mark
Novel F8 and F9 gene variants from the PedNet Hemophilia Registry classified according to ACMG/AMP guidelines
- Contribution to journal › Article
- 2019
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
- Contribution to journal › Letter
